Parth Desai

National Institutes of Health - Bethesda / United States

Others

AD Scientific Index ID: 4388774

Registration, Add Profile,
Premium Membership

Print Your Certificate

Parth Desai's MOST POPULAR ARTICLES

1-) Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stressA Thomas, N Takahashi, VN Rajapakse, X Zhang, Y Sun, M Ceribelli, ...Cancer Cell 39 (4), 566-579. e7, 20211112021

2-) MYC/BCL6 Double Hit Lymphoma (DHL): A Tumor Associated with an Aggressive Clinical Course and Poor Prognosis.MLJ Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD ...Histopathology., 2015105*2015

3-) P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B …XJ Wang, L Jeffrey Medeiros, CE Bueso-Ramos, G Tang, S Wang, Y Oki, ...Modern Pathology 30 (2), 194-203, 2017672017

4-) Prognostic impact of CD 5 expression in diffuse large B‐cell lymphoma in patients treated with rituximab‐EPOCHB Thakral, LJ Medeiros, P Desai, P Lin, CC Yin, G Tang, JD Khoury, S Hu, ...European Journal of Haematology 98 (4), 415-421, 2017712017

5-) Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived modelsD Lissa, N Takahashi, P Desai, I Manukyan, CW Schultz, V Rajapakse, ...Nature communications 13 (1), 2023, 2022682022

ARTICLES

Add your articles